Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX) resulting from ...
Scorpion Capital has assigned a target price of $0 to TransMedics stock, suggesting the firm believes the company's alleged misconduct poses an existential threat. Hagens Berman's Investigation of ...
If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a ...
On January 10, 2025, Scorpion Capital issued a report about the Company alleging fraud, organ trafficking, and off-label device misuse. It stated that in “20 years of shorting, TransMedics is ...
Zacks.com on MSN5d
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?TransMedics Group, Inc. TMDX investors are continuing to encounter losses from the stock of late. Shares of the Andover, MA-based commercial-stage medical technology company providing organ transplant ...
The Federal Reserve's aggressive interest rate hikes have increased the cost of capital for businesses. For TransMedics, which relies on heavy infrastructure and research and development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback